Needle-less Coagulation Factor Replacement Kit
The FDA has approved four enhancements for Wyeth’s BeneFIX Coagulation Factor IX (Recombinant): a 2,000 IU vial, a needle-less reconstitution device, a pre-filled syringe, and a reduced volume of diluent.
The R2 Kit is easier to prepare than the original BeneFIX kit. BeneFIX replaces clotting factor IX to stop or prevent bleeding in people with hemophilia B who do not have enough factor IX of their own. cefdinir 300mg
The new features allow patients currently using the most common dosage strength—1,000 IU— to use a lower volume of diluent to administer the product. The final infusion volume can be reduced up to 75%, and the risk of needlesticks during reconstitution is also reduced.
